We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

  • $ 4 995
  • Industry report
  • by GBI Research
  • September 2014
  • 96 pages

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting Summary GBI Research, the leading business intelligence provider, has released its latest research, ‘Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets ...

Industries: Pathology | Countries: World, Australia, India, Japan, China

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • September 2014
  • 70 pages

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023 Summary Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body ...

Industries: Pathology | Countries: Japan, World

Brainsway Ltd. (BRIN) - Product Pipeline Analysis, 2014 Update

Brainsway Ltd. (BRIN) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 32 pages

Summary Brainsway Ltd. (Brainsway) is a manufacturer of medical devices. The company develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of a wide range of neurological and psychopathological disorders. It offers deep transcranial magnetic stimulation ...

Industries: Pathology | Countries: United States, Japan

NeuroMetrix, Inc. (NURO) - Product Pipeline Analysis, 2014 Update

NeuroMetrix, Inc. (NURO) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 31 pages

Summary NeuroMetrix, Inc. (NeuroMetrix) is a medical device company. The company develops wearable medical technology and point-of-care diagnostics. It offers products such as SENSUS, DPNCheck and ADVANCE systems to its customers. NeuroMetrix's Sensus pain management system is an electrotherapy device ...

Industries: Pathology | Countries: United States, Japan

Polycystic Kidney Disease - Pipeline Review, H2 2014

Polycystic Kidney Disease - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 93 pages

Polycystic Kidney Disease - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Polycystic Kidney Disease - Pipeline Review, H2 2014', provides an overview of the Polycystic Kidney Disease's therapeutic pipeline. This report provides comprehensive information on the therapeutic development fo ...

Industries: Pathology | Countries: World, Japan

Renal Anemia - Pipeline Review, H2 2014

Renal Anemia - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 117 pages

Renal Anemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Renal Anemia - Pipeline Review, H2 2014', provides an overview of the Renal Anemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Renal Anemia, complete with comparative ...

Industries: Pathology | Countries: Japan, World, United States

Allergic Conjunctivitis - Pipeline Review, H2 2014

Allergic Conjunctivitis - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 66 pages

Allergic Conjunctivitis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Allergic Conjunctivitis - Pipeline Review, H2 2014', provides an overview of the Allergic Conjunctivitis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Allergic ...

Industries: Pathology | Countries: World, United States, Japan

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • August 2014
  • 43 pages

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport waste molecules from the blood to the urine. ...

Industries: Pathology | Countries: Japan, China, World, United States, Spain, Italy, France, Germany

Alzheimer's Disease Therapeutics and Diagnostics Market Forecast 2014-2024 : Opportunities for Leading Companies

Alzheimer's Disease Therapeutics and Diagnostics Market Forecast 2014-2024 : Opportunities for Leading Companies

  • $ 3 013
  • Industry report
  • by Visiongain
  • August 2014
  • 182 pages

Report Details Alzheimer's medicine - your guide to technologies, trends and revenues Where is the Alzheimer's disease treatment market heading? Visiongain's new report gives you revenue predictions for those drugs and diagnostic tests from 2014, helping you stay ahead. Our 182-page report provides 131 ...

Industries: Pathology | Countries: United States, World, Europe, Italy, Japan, France, China, Brazil, United Kingdom, Spain, Russian Federation, Germany, India

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States, Spain, South Korea, Japan, China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.